History of Present Illness: 87 YO male with Parkinson's disease, recently dx shingles on left foot, leg and seen by Dermatology 1 day prior to admission and Tx with Valtrex that is admitted with MS changes and intubated for airway protection.
In the ED, the patient was intubated for airway protection and and LP was performed- 47 WBC, 90L, 10M, Prot 137, & glucose 78.
Pt received 5L of NS, Acyclovir 800 mg IV, Ceftriaxone 2g IV, Vancomycin 1g IV, and Dexamethasone 6mg IV Q6H.
Pt was sedated with Fentanyl 300 mcg & Versed 19 mg.  Past Medical History: 1.
Coccygeal skin breakdown.
He is being followed by Physical Therapy at home.
He walks with a walker or uses a wheelchair.
Physical Exam: 98.0 84 133/72 NBP 14 99% SpO2 AC 450/14 PEEP 5 FiO2 50% Sedated, intubated and responded to painful stimuli.
[**2154-5-8**] 03:53PM   TYPE-ART PO2-61* PCO2-38 PH-7.35 TOTAL CO2-22 BASE XS--3 [**2154-5-8**] 03:53PM   LACTATE-1.5 [**2154-5-8**] 02:13PM   GLUCOSE-143* UREA N-11 CREAT-0.6 SODIUM-142 POTASSIUM-3.8 CHLORIDE-112* TOTAL CO2-22 ANION GAP-12 [**2154-5-8**] 02:13PM   ALT(SGPT)-5 AST(SGOT)-23 LD(LDH)-171 ALK PHOS-56 AMYLASE-182* TOT BILI-0.4 [**2154-5-8**] 02:13PM   LIPASE-15 [**2154-5-8**] 02:13PM   ALBUMIN-3.0* CALCIUM-7.7* PHOSPHATE-1.9* MAGNESIUM-1.9 [**2154-5-8**] 02:13PM   TSH-0.41 [**2154-5-8**] 02:13PM   WBC-8.8 RBC-3.47* HGB-11.6* HCT-34.5* MCV-99* MCH-33.5* MCHC-33.7 RDW-13.5 [**2154-5-8**] 02:13PM   PLT COUNT-199 [**2154-5-8**] 02:13PM   PT-12.5 PTT-35.0 INR(PT)-1.1 [**2154-5-8**] 04:42AM   TYPE-ART PO2-533* PCO2-36 PH-7.39 TOTAL CO2-23 BASE XS--2 -ASSIST/CON INTUBATED-INTUBATED [**2154-5-8**] 02:03AM   LACTATE-2.6* [**2154-5-7**] 10:35PM CEREBROSPINAL FLUID (CSF)  PROTEIN-137* GLUCOSE-78 [**2154-5-7**] 10:35PM CEREBROSPINAL FLUID (CSF)  WBC-47 RBC-143* POLYS-0 LYMPHS-90 MONOS-0 MACROPHAG-10 [**2154-5-7**] 10:35PM CEREBROSPINAL FLUID (CSF)  WBC-80 RBC-920* POLYS-3 LYMPHS-93 MONOS-0 EOS-1 MACROPHAG-3 [**2154-5-7**] 09:25PM URINE  COLOR-Amber APPEAR-Clear SP [**Last Name (un) 155**]-1.024 [**2154-5-7**] 09:25PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-15 BILIRUBIN-NEG UROBILNGN-1 PH-5.0 LEUK-NEG [**2154-5-7**] 08:36PM   LACTATE-3.3* [**2154-5-7**] 08:30PM   GLUCOSE-138* UREA N-16 CREAT-0.7 SODIUM-140 POTASSIUM-4.1 CHLORIDE-104 TOTAL CO2-22 ANION GAP-18 [**2154-5-7**] 08:30PM   CK(CPK)-102 [**2154-5-7**] 08:30PM   cTropnT-<0.01 [**2154-5-7**] 08:30PM   CK-MB-1 [**2154-5-7**] 08:30PM   CALCIUM-9.0 PHOSPHATE-2.5* MAGNESIUM-2.0 [**2154-5-7**] 08:30PM   WBC-6.0 RBC-3.95* HGB-13.1* HCT-38.8* MCV-98 MCH-33.0* MCHC-33.7 RDW-13.0 [**2154-5-7**] 08:30PM   NEUTS-72.8* LYMPHS-22.5 MONOS-3.8 EOS-0.7 BASOS-0.3 [**2154-5-7**] 08:30PM   MACROCYT-1+ [**2154-5-7**] 08:30PM   PLT COUNT-208 [**2154-5-7**] 08:30PM   PT-11.5 PTT-29.0 INR(PT)-1.0  Brief Hospital Course: 87 M with PMH Parkinson's with disseminated zoster.
Patient was found to be unresponsive to physicians and his daughter (primary caregiver), and he was intubated for airway protection and transferred to the MICU.
Upon mental status change, patient was placed on Ceftriaxone and Vancomycin for prophylaxis to bacterial meningitis (was discontinued 24 hrs later).
Patient was placed on Acyclovir 10 mg/kg (700 mg IV TID), for a course to be continued for 21 days total.
Patient developed a rash over his eyes, which ID felt was seborrheic dermatitis and not linked with zoster ophthalmicus.
Patient was not placed on steroids for concern of immunosuppression, and patient has no post-herpetic neuralgia complications.
Patient was hydrated with NS 3L per day, since acyclovir can cause renal failure.
Patient had a R picc placed by IR here, and the L picc was removed.
Patient was discharged on Day 9 Acyclovir 700 mg IV TID (to be completed for 21 days), 2L NS IVF per day, and standing 20 mEq KCl for chronically low K inhouse.
Other etiology for hypokalemia could not be found (patient was not hypertensive).
# Anemia of chronic disease: Patient's Hct remained stable in the low 30s, high 20s throughout admission.
Initial Hct drop was attributed to active IVF hydration because of treatment with acyclovir.
TIBC and transferrin were found to be low, indicative of anemia of chronic disease.
Patient was guaiac negative, with hemolysis labs wnl.
# Parkinson's disease: Patient was continued on Sinemet inhouse.
Patient was cleared by speech and swallow eval to have food of ground consistency with thin fluids.
# IV access: A picc had been placed in the patient's left arm that stopped in the axillary vein.
IR placed a picc line in the patient's right arm that is properly placed, and L picc line was removed.
Sinemet 25/100 mg divided as follows: 1-1/2 tablets at 5:30 a.m., 1-1/2 tablets at 9:30 a.m., 1-1/2 tablets at 1:30 p.m., 1 tablet at 5 p.m., 1 tablet at 9 p.m., and 1 tablet at 2 a.m.
Protonix 40 mg p.o.
Doxazosin 2 mg p.o.
Colace 5.
Vitamin C 500 mg p.o.
Multivitamin 1 p.o.
Tamsulosin 0.4 mg Capsule, Sust.
Carbidopa-Levodopa 25-100 mg Tablet Sig: One (1) Tablet PO TID (3 times a day).
Carbidopa-Levodopa 25-100 mg Tablet Sig: One (1) Tablet PO TID (3 times a day).
Bisacodyl 10 mg Suppository Sig: One (1) Suppository Rectal HS (at bedtime) as needed.
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q4-6H (every 4 to 6 hours) as needed.
Acyclovir Sodium 500 mg Recon Soln Sig: Five Hundred (500) mg Intravenous  Q8H (every 8 hours) for 13 days.
Potassium Chloride 8 mEq Tablet Sustained Release Sig: Three (3) Tablet Sustained Release PO once a day for 14 days.
Lactulose (for Encephalopathy) 10 g/15 mL Solution Sig: Thirty (30) ml PO every eight (8) hours as needed for constipation for 5 days.
